Jan 2020 - Global Life Science Business Partnering - News & Updates

Highlights of January 2020

  1. Integrace Pvt Ltd to acquire Glenmark Pharmaceuticals’ gynaecology business in India and Nepal for about US$16 Million.
  2. Sun Pharma and US-based Rockwell Medical enter into licensing pact for Triferic in India.
  3. Zydus, China Medical System Enter Licensing Agreement for Desidustat in Greater China.
  4. Strides to acquire 18 ANDAs from Pharmaceutics International
  5. Agilent inks agreement with IIT Delhi to enhance biotherapeutics.
  6. Getinge acquires Applikon Biotechnology.
  7. Incyte pays US$750 Million upfront for rights to MorphoSys cancer drug.
  8. Teladoc to buy enterprise telehealth solutions provider InTouch Health in US$600 Million deal.
  9. Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan.
  10. Tilt Biotherapeutics, Biotheus team up on tumor-targeting virus.
  11. Boehringer Ingelheim partners with Enleofen to develop first-in-class anti-IL-11 therapies for a range of fibrotic diseases.
  12. US biopharma firm Denovo Biopharma has entered into an exclusive option-to-license agreement with Rumpus Therapeutics for selected indications for DB102.
  13. Neuraxpharm Strengthens Expansion into Austrian Market with Acquisition of Easypharm.
  14. Ritter Pharmaceuticals to Be Acquired by Qualigen.

Updates at Aagami

  1. Aagami completed a very successful JPM week in San Francisco with more than 40one-to-one strategic partnering meetings.
  2. Aagami received a new assignment from an existing client for strategic partnering of their Drug-device combination to prevent Hangover and Asian Flush based on FDA-approved material.

Some of the partnering opportunities available at Aagami are:

  1. Available for Licensing: DriDose® - a Platform Technology for the delivery of a dry powder drug formulation into the nasal cavity.
  2. Available for IP Acquisition: Next-Generation PEGylation(PharmaPEG®) technology & associated assets.
  3. Seeking Investment / Partnering: Drug to treat alcohol poisoning(Breakthrough, life-saving); Another Drug to prevent hangover and Asian Flush; quick to market solution which works safely and efficiently.
  4. Seeking Investment & Partnering: Algae Technology - for Beta Carotene, Lutein, DHA and others (Innovative Process and Cost Optimized).
  5. Available for Licensing: Selection Technology using Bacteriocin-Immunity for Improved Microbial (E. coli.) Fermentation.
  6. Available for Licensing: Diabetic drug for the treatment of severe hypoglycaemic reactions using Dridose® nasal dry powder formulation; successfully completed a proof of concept clinical trial.
×
Twitter